Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05384704 · ClinicalTrials.gov registry record · NA

A Single Group Study of Empower@Home-an Internet Cognitive Behavioral Therapy Intervention

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
240
Enrollment target

NCT05384704: Completed NA study, sponsored by University of Michigan.

NCT05384704 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05384704, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
240 participants
Enrollment target

Study Summary

This is a single group study of a novel internet-based cognitive behavioral therapy program for older adults with elevated depressive symptoms. This study will enroll approximately 300 older adults throughout the state of Michigan to test the effectiveness of Empower@Home with older adults. The intervention will take approximately 10 weeks to complete. Participants will have lower levels of depression after completing the intervention than before enrollment. Participants will be able to use the internet-based platform with minimal support.

Primary Outcome

Change in 9 item standardized measures of depressive symptom severity. PHQ-9 score ranges from 0 to 27, with a higher score indicating more severe symptoms.

Interventions

  • BEHAVIORAL Empower@Home

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2022-05-23
Est. Completion 2024-03-30
Phase NA
University of Michigan

1,327 total trials

What the finished NCT05384704 record still lists

NCT05384704 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 1 intervention - of which Empower@Home is the first listed.

NCT05384704 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05384704 about?

NCT05384704 is a clinical study titled "A Single Group Study of Empower@Home-an Internet Cognitive Behavioral Therapy Intervention". This is a single group study of a novel internet-based cognitive behavioral therapy program for older adults with elevated depressive symptoms. This study will enroll approximately 300 older adults throughout the state of Michigan to test the effectiveness of Empower@Home with older adults. The inte...

What is the current status of trial NCT05384704?

This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2022-05-23. Estimated completion is 2024-03-30.

What interventions are being tested in trial NCT05384704?

The interventions under investigation include: Empower@Home (BEHAVIORAL).

Who is sponsoring clinical trial NCT05384704?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05384704's enrollment target sits among peer trials

240 440th of 2000 higher than 1,542 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05384704, the US trial registry maintained by the National Library of Medicine. NCT05384704 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.